floxuridine has been researched along with Left Ventricular Dysfunction in 1 studies
Floxuridine: An antineoplastic antimetabolite that is metabolized to fluorouracil when administered by rapid injection; when administered by slow, continuous, intra-arterial infusion, it is converted to floxuridine monophosphate. It has been used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
floxuridine : A pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bax, JJ | 1 |
Cornel, JH | 1 |
Visser, FC | 1 |
Fioretti, PM | 1 |
van Lingen, A | 1 |
Huitink, JM | 1 |
Kamp, O | 1 |
Nijland, F | 1 |
Roelandt, JR | 1 |
Visser, CA | 1 |
1 other study available for floxuridine and Left Ventricular Dysfunction
Article | Year |
---|---|
Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography.
Topics: Echocardiography; Female; Floxuridine; Fluorine Radioisotopes; Humans; Male; Middle Aged; Myocardial | 1997 |